Expression of genes encoding matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in normal and diseased canine mitral valves.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Comparative Pathology

• Publication date

  2009-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jcpa.2009.01.001PMID 19285315
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An immunohistochemical study of the role of matrix metalloproteinases and their tissue inhibitors in chronic mitral valvular disease (valvular endocardiosis) in dogs.

  2009cited by this paper
• Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves

  2007cited by this paper
• Genomic expression patterns of mitral valve tissues from dogs with degenerative mitral valve disease.

  2006cited by this paper
• Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.

  2005cited by this paper
• Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve.

  2005cited by this paper
• Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration.

  2004cited by this paper
• New insights into degenerative mitral valve disease in dogs.

  2004cited by this paper
• Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds.

  2004cited by this paper
• Increased NADPH-diaphorase activity in canine myxomatous mitral valve leaflets.

  2003cited by this paper
• Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry

  2003cited by this paper
• Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.

  2002cited by this paper
• Expression of MMP2, MMP9, MT1‐MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart

  2001cited by this paper
• Activated Interstitial Myofibroblasts Express Catabolic Enzymes and Mediate Matrix Remodeling in Myxomatous Heart Valves

  2001cited by this paper
• Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation*

  2000cited by this paper
• Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat.

  2000cited by this paper
• Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling.

  2000cited by this paper
• Incidence and morphology of endometrial angiopathies in mares in relationship to age and parity.

  1998cited by this paper
• Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules*

  1997cited by this paper
• Specific, High Affinity Binding of Tissue Inhibitor of Metalloproteinases-4 (TIMP-4) to the COOH-terminal Hemopexin-like Domain of Human Gelatinase A

  1997cited by this paper
• Pathology of chronic mitral valvular disease in the dog.

  1980cited by this paper
• Chronic valvular disease (endocardiosis) in dogs.

  1977cited by this paper
• [Enzyme histocytochemical studies of atrioventricular heart valves in endocardiosis in the dog].

  1973cited by this paper
• Enzymhistochemie der Atrioventrikularklappen bei Endokardiose des Hundes

  1973cited by this paper
• Cardiovascular pathology.

  1967cited by this paper

• The Potential of Intertwining Gene Diagnostics and Surgery for Mitral Valve Prolapse

  2023cites this paper
• Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease

  2023cites this paper
• Genetics of canine myxomatous mitral valve disease.

  2021cites this paper
• The relationship between serum pregnancy-associated plasma protein-A level in patients with aortic valve stenosis: a case-control study

  2020cites this paper
• Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.

  2020cites this paper
• Fluoroquinolones and Aortic Diseases: Is There a Connection

  2019cites this paper
• Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis

  2018influential citation
• Association of matrix metalloprotease 1, 3, and 12 polymorphisms with rheumatic heart disease in a Chinese Han population

  2018cites this paper
• Effects of transforming growth factor-β and interleukin-1β on inflammatory markers of osteoarthritis in cultured canine chondrocytes.

  2017cites this paper
• Comparative Transcriptomic Profiling and Gene Expression for Myxomatous Mitral Valve Disease in the Dog and Human

  2017cites this paper
• Myxomatous Degeneration of the Canine Mitral Valve: From Gross Changes to Molecular Events.

  2017cites this paper
• Associations of rs 3918242 and rs 2285053 MMP-9 and MMP-2 polymorphisms with the risk , severity , and short-and long-term complications of degenerative mitral valve diseases : a 4 . 8-year prospective cohort study

  2016cites this paper
• Associations of rs3918242 and rs2285053 MMP-9 and MMP-2 polymorphisms with the risk, severity, and short- and long-term complications of degenerative mitral valve diseases: a 4.8-year prospective cohort study.

  2016cites this paper
• Connecting Structural Changes to Cell Transformation Patterns in the Canine Degenerative Mitral Valve

  2015cites this paper
• Severity of Mitral Valve Degeneration Is Associated with Chromosome 15 Loci in Whippet Dogs

  2015cites this paper
• Serumaktivitet av matrix metalloproteinas-2, -9 och -14 hos hundar med myxomatös mitralisklaffdegeneration

  2015cites this paper
• Short-term effect of granulocyte colony-stimulating factor in dogs with severe myxomatous mitral valve disease

  2014cites this paper
• Transcriptomic profiling of peripheral blood nucleated cells in dogs with and without clinical signs of chronic mitral valve disease

  2014cites this paper
• Tissue-engineered canine mitral valve constructs as In vitro research models for myxomatous mitral valve disease

  2014cites this paper
• Matrix metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor-β (TGF-β) in advanced canine myxomatous mitral valve disease.

  2014influential citation
• The transcriptomic profile of peripheral blood nuclear cells in dogs with heart failure

  2014cites this paper
• Role of inflammation and extracellular matrix remodelling in dogs with cardiac and systemic diseases

  2013cites this paper
• Plasma proANP and SDMA and microRNAs are associated with chronic mitral regurgitation in a pig model

  2013cites this paper
• Expression of matrix metalloproteinases, their inhibitors, and lysyl oxidase in myocardial samples from dogs with end-stage systemic and cardiac diseases.

  2013cites this paper
• Matrix metalloproteinase-1 mitral expression and -1607 1G/2G gene promoter polymorphism in mitral chordae tendinae rupture.

  2013cites this paper
• Expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases and vascular endothelial growth factor in canine mast cell tumours.

  2012cites this paper
• Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

  2012cites this paper
• Genomic and genetic aspects of heart failure in dogs - a review.

  2012cites this paper
• Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.

  2012cites this paper
• Degeneração valvar doença : atualize em diagnóstico, tratamento e prognose

  2011cites this paper
• Matrix metalloproteinases and their inhibitors in canine mammary tumors

  2011cites this paper
• Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.

  2011cites this paper
• Degenerative valve disease in dogs: update on diagnosis, treatment and prognosis

  2011cites this paper
• Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without myxomatous mitral valve disease

  year unknowncites this paper